Table 1.
Patient characteristics.
| OBMs | BIs | |||
|---|---|---|---|---|
| Gender (male/female) | 17/14 | 51/28 | ||
| Age (years) | 66 | 68 | ||
| Follow-up time (months) | 9.3 ± 2.8 | 10.8 ± 4.8 | ||
| ROI area (cm2) | 0.68 ± 0.08 | 0.67 ± 0.11 | ||
| Lesions | 205 | 120 | ||
| Primary tumor type (%) | No. of patients | No. of lesions | No. of patients | No. of lesions |
| Lung cancer | 11 (35.4%) | 90 (43.9%) | 13 (16.5%) | 19 (15.8%) |
| Breast cancer | 7 (22.5%) | 60 (29.3%) | 7 (9.0%) | 11 (9.2%) |
| Prostate cancer | 6 (19.3%) | 30 (14.6%) | 1 (1.3%) | 1 (0.8%) |
| Rectal cancer | 2 (6.0%) | 5 (2.4%) | 8 (10.0%) | 11 (9.2%) |
| Gastric cancer | 2 (6.0%) | 11 (5.4%) | 17 (21.5%) | 25 (20.8%) |
| Ovarian cancer | 1 (3.0%) | 6 (2.9%) | 0 | 0 |
| Nasopharyngeal cancer | 1 (3.0%) | 2 (0.9%) | 0 | 0 |
| Cholangiocarcinoma | 1 (3.0%) | 1 (0.5%) | 1 (1.3%) | 1 (0.8%) |
| Colon cancer | 0 | 0 | 18 (22.8%) | 27 (22.5%) |
| Esophageal cancer | 0 | 0 | 5 (6.3%) | 8(6.7%) |
| Pulmonary synovial sarcoma | 0 | 0 | 1 (1.3%) | 1 (0.8%) |
| Thymus cancer | 0 | 0 | 1 (1.3%) | 4 (3.3%) |
| Gallbladder cancer | 0 | 0 | 1 (1.3%) | 1 (0.8%) |
| Kidney cancer | 0 | 0 | 2 (2.5%) | 2 (1.7%) |
| Osteosarcoma | 0 | 0 | 1 (1.3%) | 1 (0.8%) |
| Melanoma | 0 | 0 | 1 (1.3%) | 1 (0.8%) |
| Pancreatic cancer | 0 | 0 | 1 (1.3%) | 3 (2.5%) |
| Duodenal cancer | 0 | 0 | 1 (1.3%) | 1 (0.8%) |